Moderna, Inc.·4

Apr 30, 4:13 PM ET

SAGAN PAUL 4

4 · Moderna, Inc. · Filed Apr 30, 2021

Insider Transaction Report

Form 4
Period: 2021-04-28
SAGAN PAUL
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-04-28+4,0814,081 total
    Exercise: $178.68Exp: 2031-04-28Common Stock (4,081 underlying)
  • Award

    Restricted Stock Units

    2021-04-28+703703 total
    Exercise: $0.00Common Stock (703 underlying)
Footnotes (2)
  • [F1]This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
  • [F2]The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY